Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Lentiviral vectors encoding clotting factors for gene therapy

Lentiviral vectors encoding clotting factors for gene therapy

US Patent 6808905 · Granted Oct 26, 2004

Estimated economic value: $3,460,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PDE9 inhibitors for treating sickle cell disease2025
Methods and compositions for treating phenylketonuria2020
Sampling systems and related materials and methods2020
Methods for identifying modulators of Ras using nonlinear techniques2018
Classification of kinase inhibitors using nonlinear optical techniques2016
Cadherin-11 EC1 domain antagonists for treating inflammatory joint disorders2016
Humanized antibodies targeting the EC1 domain of Cadherin-11 and related composi2015
Tetrahydronaphthyridine and tetrahydropyrido[4,3-D]pyrimidine compounds and comp2014
Method and means for producing high titer, safe recombinant lentivirus vectors2014
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof2014
Method and means for producing high titer, safe, recombinant lentivirus vectors2014
Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof2014